Skip to main content
. 2021 May 5;26(9):2703. doi: 10.3390/molecules26092703

Figure 6.

Figure 6

(A) Mechanism of MMP-2 Responsive Peptide Hybrid Liposome (MRPL) for downregulation of ECM in pancreatic tumors; (B) Rhd penetration and distribution in pancreatic tumor (PSCs/Mia-paca-2 co-implanted) tissues after 2 weeks’ treatment of the different PFD formulations; (C) quantification of the depth of Rhd penetration in tumors treated by the PFD formulations; (D) the growth curves of PSCs and Mia-paca-2 co-implanted pancreatic tumors in mice treated by the different PFD formulations, adapted with permission from [112].